Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001193125-26-056994

Options or other derivatives

  • Interim CEO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mohindru Mani · Interim CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-17 Grant or award : show line 1 in the form Stock Options +200,000 368,766 D
Loading xslF345X05/ownership.xml…